Company: IMRX
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001790340-25-000061
Chunk: 332

Company: Immuneering Corp
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 1
Chunk 332
---
,525 2,204,580 Accumulated depreciation and amortization(1,166,976)(1,081,715)Property and equipment, net$1,046,549 $1,122,865 Depreciation and amortization expense totaled $85,261 and $90,209 for the three months ended March 31, 2025 and 2024, respectively.

Note 6 – Accrued Expenses

Accrued expenses consisted of the following:March 31,2025December 31,2024Accrued professional services$309,378 $193,646 Accrued employee expenses962,338 3,583,649 Accrued research and development expenses2,042,753 1,106,872 Accrued other74,093 88,962 Total$3,388,562 $4,973,129 

Note 7 - Common Stock

The Company had 200,000,000 authorized shares of Class A common stock, $0.001 par value per share as of March 31, 2025 and December 31, 2024 of which 35,985,702 and 31,050,448 were issued and outstanding, respectively. The holders of Class A common stock are entitled one vote for each share of common stock. Dividends may be paid when, and if, 

15

declared by the Board of Directors, subject to the limitations, powers and preferences granted to the Preferred Stockholders and on a proportionate basis with holders of Class B common stock.The Company had 20,000,000 authorized shares of Class B common stock, $0.001 par value per share as of March 31, 2025 and December 31, 2024, of which no shares have been issued nor are outstanding. The holders of Class B common stock have no voting rights. Dividends may be paid when, and if, declared by the Board of Directors, subject to the limitations, powers and preferences granted to the preferred stockholders and on a proportionate basis with holders of Class A common stock.Equity OfferingsOn August 10, 2022, the Company filed a Registration Statement on Form S-3 (File No. 333-266738) (the “2022 Shelf Registration Statement”) with the SEC in relation to the registration of common stock, preferred stock, debt securities, warrants and/or units or any combination thereof in the